Colchicine Tablet, Film Coated
Product Images NDC 64380-796
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 64380-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Eb8a8f3c 400d 43ba Bb9a 5553cc340871 02)
This is a graph or chart displaying the percentage of patients who improved with different doses of Colchicine and a placebo. The X-axis may represent time or different groups while Y-axis shows the percentage of patients improved. There are two doses of Colchicine, low-dose with 1.8 mg and high-dose with 4.8 mg. The placebo resulted in 80% of patients improved. However, the meaning of “700, 00, >0 and =10” is not clear and could be possible errors during the process.*
0.6mg 30 Count (Eb8a8f3c 400d 43ba Bb9a 5553cc340871 03)
This is a description for a medication called Colchicine in the form of film-coated tablets. Each tablet contains 0.6mg of Colchicine, USP. It is necessary to store the medication at a temperature between 20°C to 25°C (68°F to 77°F). The tablets should be protected from light and stored in a tight, light-resistant container. The medication guide needs to be dispensed along with the tablets. The prescription is only for 30 tablets and it is distributed and manufactured by Stridos Pharma Science Ltd. and Siides Pharma Inc. respectively.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.